The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 09, 2021

Filed:

Oct. 05, 2015
Applicant:

The Trustees of the University of Pennsylvania, Philadelphia, PA (US);

Inventors:

Jay F. Dorsey, Media, PA (US);

Gary D. Kao, Wynnewood, PA (US);

Stephen M. Hahn, Glen Mills, PA (US);

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12Q 1/68 (2018.01); C12N 15/79 (2006.01); G01N 33/53 (2006.01); A61K 39/23 (2006.01); C07H 21/04 (2006.01); C12Q 1/6897 (2018.01); C12Q 1/6886 (2018.01); C12N 15/86 (2006.01);
U.S. Cl.
CPC ...
C12Q 1/6897 (2013.01); C12Q 1/6886 (2013.01); C07H 21/04 (2013.01); C12N 15/79 (2013.01); C12N 15/86 (2013.01); C12Q 2600/118 (2013.01); C12Q 2600/156 (2013.01); G01N 33/53 (2013.01);
Abstract

A method useful for identifying and isolating live circulating tumor cells is described. The method utilizes an adenoviral vector comprising a replication-competent adenovirus in which the E1 gene region is expressed under the control of a telomerase-specific promoter and further comprises a second expression cassette containing a marker protein, optionally fused to a detectable cell surface marker to permit detection of circulating tumor cells lacking cell surface markers. The method involves combining ex vivo a test sample from a patient suspected of having circulating tumor cells, an adenoviral probe system, and culture media for the cells. The test sample is incubated with the adenoviral system for a sufficient time to permit expression of the reporter protein. The marker gene expression can thereafter be quantitated and the marker-expressing cells may optionally be collected for further analysis.


Find Patent Forward Citations

Loading…